NEWARK, Delaware, January 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
NEWARK, Delaware, Dec. 14, 2023/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
SPRINGFIELD, Missouri, Dec. 4, 2023/BUSINESS WIRE/ — QPS Holdings, LLC, a global contract research organization, has expanded operations in Springfield, Missouri. The new facilities…
NEWARK, Delaware, Nov. 30, 2023/BUSINESS WIRE/ — Today QPS Holdings, LLC (QPS) a leading drug development Contract Research Organization (CRO), announces an agreement to sell…
TAIPEI, Taiwan, Nov. 15, 2022 /PRNewswire/ — QPS, a global contract research organization, recently opened a second preclinical research facility in Taipei, Taiwan. The…
NEWARK, Del., Aug. 26, 2022 /PRNewswire/ — QPS, a leading global contract research organization (CRO), continues to expand and align its full service preclinical,…
Press release: Umeå, March 9, 2022. Lipum AB (publ) announce that the company has entered into an agreement with QPS Netherlands BV for the…
Dr. Manuela Prokesch will lead the Neuropharmacology department of QPS Austria GmbH from January 1, 2022. QPS Holdings LLC announced that Dr. Prokesch, currently…
Newark, Delaware, July 30, 2021 – QPS, a global contract research organization (CRO) focused on bioanalytics and clinical trials, is honored to have collaborated…
Newark, Delaware, June 2, 2021 – QPS, a GLP/GCP-compliant and CLIA-certified contract research organization (CRO) delivering discovery, preclinical, and clinical drug development services since…